Cargando…
Retinoblastoma: Etiology, Modeling, and Treatment
Retinoblastoma is a retinal cancer that is initiated in response to biallelic loss of RB1 in almost all cases, together with other genetic/epigenetic changes culminating in the development of cancer. RB1 deficiency makes the retinoblastoma cell-of-origin extremely susceptible to cancerous transforma...
Autores principales: | Kaewkhaw, Rossukon, Rojanaporn, Duangnate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465685/ https://www.ncbi.nlm.nih.gov/pubmed/32824373 http://dx.doi.org/10.3390/cancers12082304 |
Ejemplares similares
-
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
por: Srimongkol, Atthapol, et al.
Publicado: (2023) -
Germline RB1 Mutation in Retinoblastoma Patients: Detection Methods and Implication in Tumor Focality
por: Rojanaporn, Duangnate, et al.
Publicado: (2022) -
A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma
por: Saengwimol, Duangporn, et al.
Publicado: (2018) -
Spectrum of germline RB1 mutations and clinical manifestations in retinoblastoma patients from Thailand
por: Rojanaporn, Duangnate, et al.
Publicado: (2018) -
Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation
por: Saengwimol, Duangporn, et al.
Publicado: (2020)